论文信息 - SAFETY AND CLINICAL ACTIVITY OF RP6530, A DUAL PI3Kδ/γ INHIBITOR, IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES: FINAL ANALYSIS OF A PHASE 1 MULTI‐CENTER STUDY - 字舞流文

SAFETY AND CLINICAL ACTIVITY OF RP6530, A DUAL PI3Kδ/γ INHIBITOR, IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES: FINAL ANALYSIS OF A PHASE 1 MULTI‐CENTER STUDY

A. Santoro | K. Pilipow | C. Carlo-Stella | A. Ferreri | E. Lugli | R. Delarue | S. Viswanadha | L. Scarfò | S. Locatelli | M. Magagnoli | L. Morello | S. Gandolfi | P. Barde | F. De Paoli | V. Pittari